Somatostatin is a peptide hormone that regulates the endocrine system. Somatostatin is secreted in the hypothalamus, inhibits the pituitary gland's secretion of growth hormone and thyroid-stimulating hormone. Somatostatin is produced in the pancreas and inhibits the secretion of other pancreatic hormones such as insulin and glucagon.
MARKET SCOPE
The "Global Short Bowel Syndrome Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the short bowel syndrome market with detailed market segmentation by type, application, and end user. The report provides key statistics on the market status of the leading short bowel syndrome market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on type the market is segmented as, octreotide, lanreotide, and pasireotide.
- Based on application the market is segmented as, acromegaly, neuroendocrine tumors (NETS), and Others.
- Based on end user the market is segmented as, hospital and pharmaceutical companies.
MARKET DYNAMICS
Drivers:
- Rising prevalence of acromegaly and NETs.
- Increasing activities R&D by the pharmaceuticals and biotechnology companies.
- Rising awareness amongst individuals regarding Somatostatin.
Restraints:
- Lack of awareness towards advanced medication.
- Whereas, high cost of treatment is expected to restrain market growth during the forecast period.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South and Central America. The short bowel syndrome market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South and Central America after evaluating political, economic, social and technological factors affecting the short bowel syndrome market in these regions.
IMPACT OF COVID-19 ON SHORT BOWEL SYNDROME MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
MARKET PLAYERS
The report covers key developments in the short bowel syndrome market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from short bowel syndrome market are anticipated to lucrative growth opportunities in the future with the rising demand for short bowel syndrome in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the short bowel syndrome market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- NOVARTIS AG
- SUN PHARMACEUTICAL INDUSTRIES LTD
- MIDATECH PHARMA PLC
- IPSEN PHARMA
- CHIASMA INC.
- PEPTRON, INC
- CRINETICS PHARMACEUTICALS
- DAUNTLESS PHARMACEUTICALS
- CAMURUS AB
- TEVA PHARMACEUTICALS INC,
- PFIZER INC.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.